Factors determining the effectiveness of oral ciclosporin in the treatment of severe childhood atopic dermatitis

Journal of Dermatological Treatment

Volumn 23, Issue 5, 2012, Pages 318-322

  Beaumont, David R ^a   Arkwright, Peter D ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

atopic dermatitis; children; ciclosporin; Staphylococcus aureus

Indexed keywords

ACICLOVIR; CYCLOSPORIN A;

ADOLESCENT; ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG DOSE TITRATION; DRUG EFFICACY; ELECTROLYTE DISTURBANCE; FEMALE; HUMAN; HYPERTENSION; INFECTION CONTROL; KAPOSI VARICELLIFORM ERUPTION; MALE; PRIORITY JOURNAL; SIDE EFFECT; SKIN INFECTION; TREATMENT RESPONSE; UREA BLOOD LEVEL;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CYCLOSPORINE; DERMATITIS, ATOPIC; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84866279621     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546634.2012.672709     Document Type: Article

References (13)

1. Sowden JM, Berth-Jones J, Ross JS, Motley RJ, Marks R, Finlay AY, Salek MS, Graham-Brown RA, et al. Doublebind, controlled, crossover study of ciclosporin n adults with severe refractory atopic dermatitis. Lancet. 1991;338: 137-140.
2. SalekMS, Finlay AY, Luscombe DK, Allen BR, Berth-Jones J, Camp RD, Graham-Brown RA, Khan GK, et al. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. a randomized, double-blind, placebo-controlled trial. Br J Dermatol. 1993;129:422-430. (Pubitemid 23308247)
3. van Joost T, Heule F, Korstanje M, van den Broek MJ, Stenveld HJ, van Vloten WA. Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study. Br J Dermatol. 1994;130:634-640. (Pubitemid 24204701)
4. Berth-Jones J, Finlay AY, Zaki I, Tan B, Goodyear H, Lewis-Jones S, Cork MJ, Bleehen SS, et al. Cyclosporine in severe childhood atopic dermatitis: a multicenter study. J Am Acad Dermatol. 1996;34:1016-1021. (Pubitemid 26170768)
5. Berth-Jones J, Graham-Brown RA, Marks R, Camp RD, English JS, Freeman K, Holden CA, Rogers SC, et al. Longterm efficacy and safety of ciclosporin in severe adult atopic dermatitis. Br J Dermatol. 1997;136:76-81. (Pubitemid 27016179)
6. Harper JI, Ahmed I, Barclay G, Lacour M, Hoeger P, Cork MJ, Finlay AY, Wilson NJ, et al. Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy. Br J Dermatol. 2000;142:52-58. (Pubitemid 30074470)
7. Schmitt J, SchmittN,MeurerM. Cyclosporin in the treatment of patients with atopic dermatitis-a systematic review and metaanalysis. J Eur Acad Dermatol Venereol. 2007;21:606-619. (Pubitemid 46916758)
8. Kunz B, Oranje AP, Labrèze L, Stalder JF, Ring J, Taïeb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European task force on atopic dermatitis. Dermatology. 1997;195:10-19. (Pubitemid 27326702)
9. Bunikowski R, Mielke M, Bräutigam M, Renz H, Wahn U. Effect of oral ciclosporin A in children with Staphylococcus aureus-colonized vs S. aureus-infected severe atopic dermatitis. Pediatr Allergy Immunol. 2003;14:55-59. (Pubitemid 36603990)
10. Campbell DE, Kemp AS. Cyclosporine restores cytokine imbalance in childhood atopic dermatitis. J Allergy Clin Immunol. 1997;99:857-859. (Pubitemid 27280382)
11. Bunikowski R, Staab D, Kussebi F, Bräutigam M, Weidinger G, Renz H, Wahn U. Low-dose ciclosporin A microemulsion in children with severe atopic dermatitis: clinical and immunological effects. Pediatr Allergy Immunol. 2001;12:216-223. (Pubitemid 32768762)
12. Schlievert PM, Case LC, Strandberg KL, Abrams BB, Leung DY. Superantigen profile of Staphylococcus aureus isolates from patients with steroid-resistant atopic dermatitis. Clin Infect Dis. 2008;46:1562-1567. (Pubitemid 351720866)
13. Suzuki H, Terai M, Hamada H, Honda T, Suenaga T, Takeuchi T, Yoshikawa N, Shibuta S, et al. Cyclosporin A Treatment for Kawasaki disease refractory to initial and additional intravenous immunoglobulin. Pediatr Infect Dis J. 2011;30:871-876.